Ocean Biomedical, Inc.
OCEAOTCCIK 1869974HealthcareFiscal year ends Dec 31
Reports and events: 111 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-06-1508:08 ET | S-1/A | Registration statement, amended | 0001493152-23-021385 |
| 2023-06-0812:56 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-23-020592 |
| 2023-06-0105:01 ET | S-1/A | Registration statement, amended | 0001493152-23-019757 |
| 2023-05-2604:01 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-019176 |
| 2023-05-2412:26 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001493152-23-018924 |
| 2023-05-1604:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001493152-23-017639 |
| 2023-04-2112:44 ET | S-1 | Registration statement | 0001493152-23-013239 |
| 2023-03-3113:17 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001493152-23-010412 |
| 2023-03-3110:33 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001493152-23-010129 |
| 2023-03-2715:04 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-008961 |
| 2023-03-2415:30 ET | SC 13D/A | Ownership report, active investor, amended | 0001493152-23-008741 |
| 2023-03-1704:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-008008 |
| 2023-02-2412:02 ET | SC 13D | Ownership report, active investor | 0001493152-23-006020 |
| 2023-02-2411:53 ET | SC 13D | Ownership report, active investor | 0001493152-23-006017 |
| 2023-02-1706:17 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-005384 |
| 2023-02-1503:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-005140 |
| 2023-02-1516:30 ET | 8-K/A | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 5.06 Item not in the standard list; 9.01 Financial statements and exhibits | 0001493152-23-005097 |
| 2023-02-1516:22 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 5.06 Item not in the standard list; 9.01 Financial statements and exhibits | 0001493152-23-005096 |
| 2023-02-1306:29 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-004412 |
| 2023-02-1304:14 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-004392 |
| 2023-02-1313:33 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-004349 |
| 2023-02-1009:55 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-004252 |
| 2023-02-0904:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-004004 |
| 2023-02-0804:34 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-003917 |
| 2023-02-0704:15 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-23-003801 |
| 2023-02-0604:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-003651 |
| 2023-02-0112:28 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-003332 |
| 2023-01-3004:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-002865 |
| 2023-01-2404:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-002272 |
| 2023-01-1312:10 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-001461 |
| 2023-01-1208:59 ET | DEF 14A | Proxy statementPeriod 2023-01-12 | 0001493152-23-001281 |
| 2022-12-1603:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-035673 |
| 2022-12-1304:09 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-035252 |
| 2022-12-0803:01 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-22-034826 |
| 2022-11-2111:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-22-033099 |
| 2022-11-0407:23 ET | 8-K/A | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-030426 |
| 2022-11-0108:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-030076 |
| 2022-11-0105:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-030067 |
| 2022-10-1712:05 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001493152-22-028552 |
| 2022-10-0503:50 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-22-027656 |
| 2022-09-2203:45 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-026524 |
| 2022-09-1903:45 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-026171 |
| 2022-09-1205:20 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-025581 |
| 2022-09-0913:14 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-22-025519 |
| 2022-09-0813:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-025398 |
| 2022-09-0817:42 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-22-025301 |
| 2022-09-0603:45 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-025056 |
| 2022-08-3104:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-024442 |
| 2022-07-1912:45 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001493152-22-019839 |
| 2022-07-1112:35 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001493152-22-019014 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.